0 items USD 0.00Search
Your search for "current partnering biocon partnering deals alliances 2010 2017" gave back 100 results.
Alzheimer’s disease is the most common cause of dementia among older people. It is a devastating condition for those afflicted as well as their...
iGATE
July 2017
Price: USD 1,250.00
Pharmaceutical Deal Trends (2010–2015) and In-Depth Analysis of Recent Deal Activity Summary GBI Research’s latest report, "Pharmaceutical Deal...
CBR Pharma Insights
October 2015
Price: USD 2,995.00
Global Biosimilars Market - Increasingly Lucrative Market Fueled by Constrained Payer Environment and Patent Expiries for Best-Selling Biologics...
Catalog:
CBR Pharma Insights
January 2019
Price: USD 2,995.00
RNA-Targeted Small Molecules 2019: a landscape analysis of companies, technologies, targets, investors and partners from an industry perspective This...
Catalog:
La Merie Publishing
September 2019
Price: USD 2,350.00
This report provides a landscape description and analysis of chimeric antigen receptor-macrophage (CAR-M) platform technologies and stakeholders from...
Catalog:
La Merie Publishing
February 2023
Price: USD 2,000.00
Targeted Protein Degradation by Novel PROTACs and Molecular Glues 2020: a landscape analysis of companies, technologies, targets, investors and...
Catalog:
La Merie Publishing
May 2020
Price: USD 2,350.00
RNA-Targeted Novel Drug Modalities Based on RNA Editing, Epitranscriptomics, Direct RNA Targeting, Splicing Modulation, Translation Regulation,...
Catalog:
La Merie Publishing
November 2022
Price: USD 2,500.00
The biosimilars are poised to capture an unprecedented position in the biopharmaceutical industry driven by an increased extent of adoption and...
Catalog:
iGATE
October 2016
Price: USD 1,350.00
Strategic Trends in Private Equity and Venture Capital Funding for Healthcare Summary GBI Research’s latest report, "Strategic Trends in Private...
Catalog:
CBR Pharma Insights
November 2016
Price: USD 2,995.00
The global neuromodulation market is poised to cross US$ 5 Billion mark by 2021. Neuromodulation is a technology that acts directly upon nerves. It...
Catalog:
iGATE
October 2016
Price: USD 1,250.00
Exosome Technologies: Recent Surge in R&D with Capricor, Codiak and Evox Therapeutics among Key Players Summary GBI Research’s latest report,...
Catalog:
CBR Pharma Insights
October 2018
Price: USD 2,995.00
This report evaluates Receptor tyrosine kinase-like Orphan Receptor 1 (ROR1) from an industry perspective for its suitability as a tumor-specific...
Catalog:
La Merie Publishing
June 2022
Price: USD 1,170.00
This report evaluates G-protein–coupled receptor family C group 5 member D (GPRC5D) from an industry perspective for its suitability as a tumor-...
Catalog:
La Merie Publishing
July 2022
Price: USD 670.00
The molecular diagnostics market is one of the most rapidly growing segments of the in vitro diagnostics industry. Molecular diagnostics is a new...
Catalog:
iGATE
September 2016
Price: USD 1,100.00
Cadherins are a family of glycoproteins responsible for calcium ion–dependent cell adhesion. There are more than 100 types of cadherins in humans,...
Catalog:
La Merie Publishing
May 2022
Price: USD 450.00
